Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research note issued to investors on Sunday. The firm set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $7.00 target price on shares of Aethlon Medical in a research note on Friday, November 15th.

Aethlon Medical Stock Up 4.9 %

NASDAQ:AEMD opened at $0.40 on Friday. The company has a market capitalization of $5.64 million, a P/E ratio of -0.14 and a beta of 1.74. Aethlon Medical has a 52 week low of $0.24 and a 52 week high of $2.35. The stock’s fifty day moving average is $0.40 and its two-hundred day moving average is $0.45.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.